TCW Group Inc. Buys 1,709 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

TCW Group Inc. lifted its stake in Henry Schein, Inc. (NASDAQ:HSIC) by 6.5% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 28,077 shares of the company’s stock after purchasing an additional 1,709 shares during the quarter. TCW Group Inc.’s holdings in Henry Schein were worth $1,943,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also recently made changes to their positions in HSIC. Mirae Asset Global Investments Co. Ltd. boosted its position in shares of Henry Schein by 32.5% in the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 12,204 shares of the company’s stock worth $894,000 after purchasing an additional 2,992 shares in the last quarter. DekaBank Deutsche Girozentrale raised its holdings in Henry Schein by 13.1% in the 3rd quarter. DekaBank Deutsche Girozentrale now owns 953,792 shares of the company’s stock worth $69,498,000 after acquiring an additional 110,270 shares during the last quarter. Deroy & Devereaux Private Investment Counsel Inc. raised its holdings in Henry Schein by 0.7% in the 3rd quarter. Deroy & Devereaux Private Investment Counsel Inc. now owns 47,055 shares of the company’s stock worth $3,430,000 after acquiring an additional 325 shares during the last quarter. Stephens Investment Management Group LLC raised its holdings in Henry Schein by 8.9% in the 3rd quarter. Stephens Investment Management Group LLC now owns 179,716 shares of the company’s stock worth $13,101,000 after acquiring an additional 14,631 shares during the last quarter. Finally, Farther Finance Advisors LLC raised its holdings in Henry Schein by 58.9% in the 3rd quarter. Farther Finance Advisors LLC now owns 933 shares of the company’s stock worth $68,000 after acquiring an additional 346 shares during the last quarter. 96.62% of the stock is owned by institutional investors.

Henry Schein Trading Up 0.5 %

NASDAQ:HSIC opened at $77.64 on Tuesday. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. The firm has a market capitalization of $9.68 billion, a price-to-earnings ratio of 31.95, a price-to-earnings-growth ratio of 2.13 and a beta of 0.91. Henry Schein, Inc. has a one year low of $63.67 and a one year high of $82.63. The business has a fifty day moving average price of $74.19 and a 200-day moving average price of $72.38.

Wall Street Analysts Forecast Growth

HSIC has been the subject of a number of recent analyst reports. Bank of America upgraded shares of Henry Schein from an “underperform” rating to a “buy” rating and boosted their price objective for the stock from $69.00 to $84.00 in a report on Monday, January 6th. Wells Fargo & Company initiated coverage on shares of Henry Schein in a report on Friday, February 14th. They issued an “equal weight” rating and a $80.00 price objective for the company. Jefferies Financial Group boosted their price objective on shares of Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a report on Thursday, January 23rd. Mizuho started coverage on shares of Henry Schein in a report on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 price objective for the company. Finally, Barrington Research boosted their target price on shares of Henry Schein from $82.00 to $90.00 and gave the company an “outperform” rating in a research note on Thursday, January 30th. Eight equities research analysts have rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, Henry Schein presently has a consensus rating of “Moderate Buy” and an average target price of $80.09.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.